NOVONESIS (NOVOZYMES) B (NZM2.DE) Stock Income Statement
Europe - FRA:NZM2 - DK0060336014 - Common Stock
51.1 EUR
-0.06 (-0.12%)
| 2024 (2024-12-31) | 2023 (2023-12-31) | 2022 (2022-12-31) | 2021 (2021-12-31) | 2020 (2020-12-31) | ||||
|---|---|---|---|---|---|---|---|---|
| Revenue | 3.83B | 2.40B | 2.35B | 2.01B | 14.01B | |||
| Minority Interest Expense | 0.00 | -2.01M | -1.34M | 134.10K | -1.00M | |||
| Cost Of Goods | 2.02B | 1.10B | 1.07B | 846.61M | 6.16B | |||
| Gross Profit | 1.81B | 1.30B | 1.28B | 1.16B | 7.85B | |||
| Operating Expenses | 1.15B | 704.48M | 686.13M | 631.77M | 4.24B | |||
| Research and Development | 333.40M | 232.46M | 221.74M | 222.88M | 1.62B | |||
| Selling, General, and Administrative Expenses | 659.50M | 416.82M | 400.34M | 345.99M | 2.16B | |||
| Operating Income | 659.00M | 598.10M | 597.03M | 526.63M | 3.61B | |||
| Interest Income/Expense | -72.10M | -20.37M | -50.65M | -10.06M | -100.00M | |||
| Other Income/Expense | -11.80M | 11.12M | 14.20M | -1.07M | -31.00M | |||
| Non Recurring Items | -158.00M | -65.12M | 49.84M | 10.73M | 42.00M | |||
| Income Before Taxes | 417.10M | 523.74M | 610.43M | 526.23M | 3.52B | |||
| Income Tax | 111.30M | 116.57M | 116.57M | 104.47M | 695.00M | |||
| Net Income | 305.80M | 405.17M | 492.52M | 421.90M | 2.83B | |||
| EBITDA | 1.26B | 784.20M | 795.99M | 716.53M | 4.88B | |||
| Per Share Data | ||||||||
| EPS Diluted Total Ops | 0.67 | 1.46 | 1.77 | 1.51 | 10.02 | |||
| Non GAAP EPS | N/A | 3.90 | 13.20 | 11.23 | 10.02 | |||
| Statistics | ||||||||
| Gross Profit Margin | 47.20% | 54.32% | 54.56% | 57.78% | 56.04% | |||
| Profit Margin | 7.98% | 16.89% | 20.94% | 21.04% | 20.16% | |||
| Operating Profit Margin | 17.19% | 24.94% | 25.39% | 26.27% | 25.76% | |||
All data in EUR